The results of a recent study indicate the prevalence of allergic reactions after adults who are at high risk for anaphylactic reactions receive the Pfizer-BioNtech COVID-19 vaccination.

This COVID-19 roundup discusses the recent authorization of a monoclonal antibody as COVID-19 prevention, the prevalence and prevention of long COVID-19, and an additional COVID-19 vaccine dose for patients...

This COVID-19 roundup discusses potential long-term pulmonary damage following infection, the accuracy of saliva testing vs nasal swabs, expert opinion on the call for booster doses, and the impact of a...

After an in-depth analysis and review of the data, the US Food and Drug Administration has fully approved the first COVID-19 vaccine for individuals aged 16 years or older.

As the Delta variant causes another COVID-19 surge within the United States, booster doses for the COVID-19 vaccine may soon be recommended for all individuals.

This COVID-19 roundup discusses the authorization of a third vaccine dose in certain populations, the efficacy of different vaccines against breakthrough cases, drinking patterns among college students, and...

The Centers for Disease Control and Prevention have issued recommendations on the vaccination of pregnant women and women planning to become pregnant.

In a recent study, researchers examined illness characteristics in symptomatic school-aged children with COVID-19.

This COVID-19 roundup discusses a recent vaccine warning, infection by multiple variant strains, viral clearance following medication, and booster doses for the COVID-19 vaccines.

This COVID-19 roundup discusses potential new treatments including anti-coagulants and monoclonal antibody combinations, the latest mask recommendations from the World Health Organization, and long-term...